NO20040551L - Hydroksaminsyrederivater. - Google Patents

Hydroksaminsyrederivater.

Info

Publication number: NO20040551L
Authority: NO; Norway
Prior art keywords: cfh; acid derivatives; hydroxamic acid; compounds; hydrogen atom
Prior art date: 2001-08-09

Application number

NO20040551A

Other languages

English (en)

Norwegian (no)

Inventor

Hazel Joan Dyke

Robert Watson

Original Assignee

Celltech R&D Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-09

Filing date

2004-02-06

Publication date

2004-05-10

2004-02-06 Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd

2004-05-10 Publication of NO20040551L publication Critical patent/NO20040551L/no

Links

NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
239000002253 acid Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
208000006820 Arthralgia Diseases 0.000 abstract 1
229940124761 MMP inhibitor Drugs 0.000 abstract 1
208000000491 Tendinopathy Diseases 0.000 abstract 1
206010043255 Tendonitis Diseases 0.000 abstract 1
238000010171 animal model Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
201000004415 tendinitis Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)

NO20040551A 2001-08-09 2004-02-06 Hydroksaminsyrederivater. NO20040551L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0119396.0A GB0119396D0 (en)	2001-08-09	2001-08-09	Hydroxamic acid derivatives
PCT/GB2002/003656 WO2003014101A1 (en)	2001-08-09	2002-08-07	Hydroxamic acid derivatives

Publications (1)

Publication Number	Publication Date
NO20040551L true NO20040551L (no)	2004-05-10

Family

ID=9920067

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040551A NO20040551L (no)	2001-08-09	2004-02-06	Hydroksaminsyrederivater.

Country Status (21)

Country	Link
US (1)	US7015234B2 (de)
EP (1)	EP1414812B1 (de)
JP (1)	JP2005501090A (de)
KR (1)	KR20040035725A (de)
CN (1)	CN1275954C (de)
AT (1)	ATE318263T1 (de)
BR (1)	BR0211780A (de)
CA (1)	CA2456291A1 (de)
DE (1)	DE60209354T2 (de)
EA (1)	EA006877B1 (de)
ES (1)	ES2257561T3 (de)
GB (1)	GB0119396D0 (de)
HU (1)	HUP0401187A2 (de)
IL (1)	IL160266A0 (de)
MX (1)	MXPA04001212A (de)
NO (1)	NO20040551L (de)
NZ (1)	NZ531521A (de)
PL (1)	PL368228A1 (de)
PT (1)	PT1414812E (de)
WO (1)	WO2003014101A1 (de)
ZA (1)	ZA200401873B (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4166452A (en) *	1976-05-03	1979-09-04	Generales Constantine D J Jr	Apparatus for testing human responses to stimuli
US4256108A (en) *	1977-04-07	1981-03-17	Alza Corporation	Microporous-semipermeable laminated osmotic system
US4265874A (en) *	1980-04-25	1981-05-05	Alza Corporation	Method of delivering drug with aid of effervescent activity generated in environment of use
US6187924B1 (en) *	1997-11-12	2001-02-13	Darwin Discovery, Ltd.	Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
BR9814147A (pt) *	1997-11-12	2000-10-03	Darwin Discovery Ltd	"derivados de ácido carboxìlico e hidroxâmico tendo atividade inibitória de mmp e tnf"
HRP20010660A2 (en) *	1999-02-08	2005-02-28	G.D. Searle & Co	Sulfamato hydroxamic acid metalloprotease inhibitor

2001
- 2001-08-09 GB GBGB0119396.0A patent/GB0119396D0/en not_active Ceased
2002
- 2002-08-07 HU HU0401187A patent/HUP0401187A2/hu unknown
- 2002-08-07 KR KR10-2004-7001959A patent/KR20040035725A/ko not_active Withdrawn
- 2002-08-07 PT PT02747621T patent/PT1414812E/pt unknown
- 2002-08-07 DE DE60209354T patent/DE60209354T2/de not_active Expired - Fee Related
- 2002-08-07 MX MXPA04001212A patent/MXPA04001212A/es unknown
- 2002-08-07 PL PL02368228A patent/PL368228A1/xx not_active Application Discontinuation
- 2002-08-07 NZ NZ531521A patent/NZ531521A/en unknown
- 2002-08-07 IL IL16026602A patent/IL160266A0/xx unknown
- 2002-08-07 US US10/485,905 patent/US7015234B2/en not_active Expired - Fee Related
- 2002-08-07 CN CNB028200225A patent/CN1275954C/zh not_active Expired - Fee Related
- 2002-08-07 EP EP02747621A patent/EP1414812B1/de not_active Expired - Lifetime
- 2002-08-07 BR BR0211780-0A patent/BR0211780A/pt not_active IP Right Cessation
- 2002-08-07 JP JP2003519051A patent/JP2005501090A/ja active Pending
- 2002-08-07 CA CA002456291A patent/CA2456291A1/en not_active Abandoned
- 2002-08-07 AT AT02747621T patent/ATE318263T1/de not_active IP Right Cessation
- 2002-08-07 WO PCT/GB2002/003656 patent/WO2003014101A1/en not_active Ceased
- 2002-08-07 EA EA200400287A patent/EA006877B1/ru unknown
- 2002-08-07 ES ES02747621T patent/ES2257561T3/es not_active Expired - Lifetime
2004
- 2004-02-06 NO NO20040551A patent/NO20040551L/no not_active Application Discontinuation
- 2004-03-08 ZA ZA200401873A patent/ZA200401873B/en unknown

Also Published As

Publication number	Publication date
CA2456291A1 (en)	2003-02-20
EP1414812B1 (de)	2006-02-22
KR20040035725A (ko)	2004-04-29
ATE318263T1 (de)	2006-03-15
WO2003014101A1 (en)	2003-02-20
DE60209354D1 (de)	2006-04-27
BR0211780A (pt)	2004-07-27
US20040192733A1 (en)	2004-09-30
GB0119396D0 (en)	2001-10-03
CN1275954C (zh)	2006-09-20
EP1414812A1 (de)	2004-05-06
NZ531521A (en)	2005-06-24
JP2005501090A (ja)	2005-01-13
DE60209354T2 (de)	2006-10-19
MXPA04001212A (es)	2004-07-08
CN1568320A (zh)	2005-01-19
ES2257561T3 (es)	2006-08-01
HUP0401187A2 (hu)	2004-12-28
IL160266A0 (en)	2004-07-25
ZA200401873B (en)	2005-03-08
US7015234B2 (en)	2006-03-21
PT1414812E (pt)	2006-05-31
EA200400287A1 (ru)	2004-06-24
EA006877B1 (ru)	2006-04-28
PL368228A1 (en)	2005-03-21

Legal Events

Date	Code	Title	Description
2008-03-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20000227D0 (no)	2000-01-17	Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmåte for dens fremstilling og dens anvendelse
NO20044731L (no)	2004-12-30	Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
IS6902A (is)	2003-07-31	N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
HUP0201659A2 (hu)	2002-11-28	Kristályos benzimidazol-vegyület
NO20044995L (no)	2005-01-18	Heterosykliske forbindelser
NO20050828L (no)	2005-04-05	lndol-3-svovelderivater
BR0114870A (pt)	2004-02-17	Tratamento de tumores estromais gastrointestinais
TR200002605T2 (tr)	2000-12-21	Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
EA200600878A1 (ru)	2006-10-27	Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar )
CY1109678T1 (el)	2014-08-13	Νεα παραγωγα 3-φαινυλπροπιονικου οξεος και χρηση αυτων ως συνδετηρες του υποδοχεα ppar-γαμμα
SE9803773D0 (sv)	1998-11-05	Compounds
IL161842A (en)	2010-12-30	2-amino-4-heteroarylethyl-thiazoline derivatives and pharmaceutical compositions comprising them
NO20080144L (no)	2008-01-14	Spiro-benzimidazoler som inhibitorer av magesyre og sekresjon
NO20023951L (no)	2002-08-20	Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
NO20060718L (no)	2006-03-01	Substituerte tiofoner og deres anvendelse
NO20040551L (no)	2004-05-10	Hydroksaminsyrederivater.
ATE420068T1 (de)	2009-01-15	Reverse hydroxamsäurederivate
NO20030500D0 (no)	2003-01-31	Dihydroporfyrinderivater og deres anvendelse
DE50308492D1 (de)	2007-12-13	Verbindungen, die faktor xa-aktiv t inhibieren
WO2004026930A3 (en)	2004-09-23	The method for reducing inflammation using sti-571 or its salt
NO20040981L (no)	2004-03-05	Fremgangsmate for fremstilling av 4-(imidazol-1-yl)benzensulfonamidderivater.
TW200519071A (en)	2005-06-16	3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives
NO20010332D0 (no)	2001-01-19	Nye 6-deoksyerytromycinderivater, metoder for fremstilling av disse, og anvendelse som medisiner
SE9901530D0 (sv)	1999-04-28	Novel compounds
ATE326970T1 (de)	2006-06-15	Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen